This document is an agent authorization letter from Shenzhen Opolo Tech Co., Ltd., dated May 27, 2025. The letter authorizes Shenzhen CTB Testing Technology Co., Ltd. to act on Shenzhen Opolo Tech Co., Ltd.'s behalf in all matters relating to equipment authorization. This includes the signing of all documents related to these matters.
The letter also certifies that no party to the application authorized is subject to the denial of benefits, including FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C.853(a). The agreement is set to expire one year from the current date. The letter is signed by Kui Sun, Manager.